1110 — Kingworld Medicines Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapContrarian

Annual income statement for Kingworld Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	978	745	847	958	1,079
Cost of Revenue
Gross Profit	267	280	264	278	281
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	901	672	775	885	982
Operating Profit	76.7	73.6	72.2	72.2	96.8
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	69.8	70.9	69.4	67.6	93.9
Provision for Income Taxes
Net Income After Taxes	50.3	50.9	51.2	43.5	61.6
Minority Interest
Net Income Before Extraordinary Items
Net Income	43.4	11.7	30.3	22.7	38.1
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	43.4	11.7	30.3	22.7	38.1
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.07	0.018	0.052	0.037	0.064
Dividends per Share